Day: November 18, 2024

VANCOUVER, British Columbia, Nov. 18, 2024 (GLOBE NEWSWIRE) — Koryx Copper Inc. (“Koryx” or the “Company“) (TSX-V: KRY) is pleased to announce that it has appointed Heye Daun as President and Chief Executive Officer (“CEO”) and Trevor Faber as Chief Operating Officer (“COO”). Heye Daun will also retain his board position as Chairman and Pierre Léveillé steps down as President and remains on the Board as Executive Director. Heye Daun, incoming President & CEO of Koryx Copper commented: “As Koryx has completed its private placement of $18M and being more than sufficiently financed to conduct Phase 2 of its drilling and study operations, I am honoured to be appointed President and CEO of the Company, which more accurately represents my day-to-day role of managing the Company. In addition, we are very pleased with...

Treatment with nomlabofusp modified gene expression and lipid profiles in addition to increasing frataxin (FXN) levels in study participants with Friedreich’s ataxia (FA) Modeling and simulation predict that, in most patients with FA, 50 mg of nomlabofusp administered daily is likely to achieve FXN levels that are ≥50% of levels observed in healthy controls and similar to mean FXN levels reported in asymptomatic heterozygous carriersDisease characteristics of adult participants in the nomlabofusp studies were representative of the broad population of adults with FA Relationships between tissue FXN levels and onset of disease and GAA repeat length observed at baseline in nomlabofusp clinical study participants were consistent with prior published studies Nomlabofusp program update expected mid-December 2024BALA CYNWYD, Pa., Nov....

Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant improvement in primary endpoint of fibromyalgia nociplastic pain and in all six key secondary endpoints, including sleep quality New Drug Application (NDA) submitted to FDA in October 2024; Fast Track designation previously granted by FDA; FDA decision on approval expected 2025 TNX-102 SL is a potential non-opioid analgesic targeting non-restorative sleep If approved by FDA, TNX-102 SL would be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug for treating fibromyalgia in more than 15 years CHATHAM, N.J., Nov. 18, 2024 (GLOBE NEWSWIRE) —  Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company),...

HOUSTON, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”) today announced the signing of multiple midstream and gathering agreements with leading industry partners in the Denver-Julesburg (DJ) Basin. These strategic partnerships secure takeaway, processing, sales, and water disposal solutions across our acreage, ensuring escalating marketing and takeaway capacity for the comprehensive development of the Company’s 44,000-acre asset base. “Securing these midstream agreements is a critical step in our growth strategy,” stated Edward Kovalik, Chairman and CEO of Prairie Operating Co. “These strategic partnerships allow us to efficiently manage production, transportation, and water disposal needs across our asset base while ensuring seamless takeaway capacity for our DJ Basin development.” Through...

VANCOUVER, British Columbia, Nov. 18, 2024 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI), the copper explorer and developer, located in Chile, is pleased to announce that it has commenced the process to dual list on the Australian Securities Exchange (the “ASX”). The ASX dual listing is part of Marimaca Copper’s growth strategy and is an important strategic step for its Marimaca Copper Project located in Antofagasta Region, Chile, as it advances through the Definitive Feasibility Study (“DFS”) and project permitting milestones and towards project development. Hayden Locke, President & CEO of Marimaca Copper, commented: “We are excited to announce Marimaca Copper’s intention to list on the ASX. This will be an important milestone for the Company as we advance the development of the...